Quest Diagnostics Launches Healthcare Initiative for Hispanic Demographic
Quest Diagnostics is launching a multi-faceted initiative to provide better healthcare among America’s large and growing Hispanic community.
Read MorePosted by Andy Lundin | Aug 4, 2022 | Company News, Covid 19 |
Quest Diagnostics is launching a multi-faceted initiative to provide better healthcare among America’s large and growing Hispanic community.
Read MorePosted by Andy Lundin | Aug 3, 2022 | Covid 19, Rapid Assays |
Researchers have developed a SARS-CoV-2 saliva assay and prototype device that combine speed and ease with high sensitivity.
Read MorePosted by Andy Lundin | Aug 2, 2022 | Covid 19 |
North American Diagnostics is recalling oral-based SARS-CoV-2 rapid tests that were distributed without authorization from the U.S. FDA.
Read MorePosted by Andy Lundin | Aug 1, 2022 | Compliance, Lab Management |
The Centers for Medicare & Medicaid Services issued a proposed rule that would update the CLIA 1988 fee regulations.
Read MorePosted by Andy Lundin | Aug 1, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Meridian Bioscience received re-authorization from the FDA of its Emergency Use Authorization (EUA) for a SARS-COV-2 molecular assay.
Read More